Loading…
Fierce Virtual Series: JPM Week 2021
Attending this event?
Back To Schedule
Monday, January 11 • 2:00pm - 2:30pm
Data driven clinical solutions to enhance cancer patient outcomes

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
The TD2/VieCure partnership offers enhanced clinical decision making and accelerated therapeutic development processes to community oncology practice with incomparable outcomes. TD2 is a precision medicine therapeutic development company with an enabled early development community oncology practice research network. The VieCure platform is a next generation oncology clinical decision-support system that combines an A.I. clinical inference engine, clinical pathways and an integrated EMR to support personalized treatment planning. The Partnership offers access to real-time, de-identified patient data to assist with site selection, feasibility, and patient identification as well as improved protocol design. Together, the combined capabilities create the foundation for a precision medicine program in the oncology community setting that delivers early responses to clinical trial targets leading to accelerated approvals of a range of therapeutics and patient access to life-saving therapies.

Speakers
avatar for Fred Ashbury, Ph.D.

Fred Ashbury, Ph.D.

Chief Scientific Officer, VieCure
Fred is a co-founder and Chief Scientific Officer at VieCure. He is responsible for developing and maintaining VieCure’s oncology clinical content, genomic-science knowledge identification and codification, and the design and implementation of the treatment strategy rules that underpin... Read More →
avatar for Susan S. Night

Susan S. Night

Vice President, Site Engagement and Network Strategy, TD2
Susan S. Night, JD, LLM is Vice President of Site Engagement and Network Strategy for Translational Drug Development (TD2), a precision oncology CRO. Before joining TD2, Ms Night served as Director, Research Optimization for US Oncology Research/McKesson Specialty Health. She started... Read More →


Monday January 11, 2021 2:00pm - 2:30pm EST